Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People of any age who have a genetic condition included on the trial's eligible conditions list, as well as their biological family members (the current list of eligible conditions can be found at the trial's official website).
- People who are fluent in English, Spanish, French, or Dutch (with more languages expected to be added).
- People who are able to take part through an online platform that can be accessed on any internet-connected device.
- People who are able and willing to give their consent to participate.
Who may not be able to join:
- People whose specific genetic change falls within a region or involves a variant that the trial's trained genetic counselors determine to be ineligible during a laboratory review — the list of ineligible regions and variants can change over time, so this is assessed on a case-by-case basis (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Cora Taylor, PhD, Geisinger Clinic
Phone: 855-329-5638
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Baseline comprehensive collection of medical, behavioral, learning, and developmental information of people who have documented gene changes that are associated with features of autism and other neurodevelopmental disorders.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.